Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
156,9 USD | +0,77% | -1,04% | +26,45% |
Attività
Numero di dipendenti: 229
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100,0
%
| 0 | nan % | 51 | 100,0 % | - |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 51 | 100,0 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 59 | 15/04/16 | |
Suma M. Krishnan
FOU | Founder | 59 | 15/04/16 |
Ram Kamineni
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/22 |
Trevor Parry
CTO | Chief Tech/Sci/R&D Officer | - | - |
George Chen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Meg Dodge
IRC | Investor Relations Contact | - | - |
Hubert Chen
PRN | Corporate Officer/Principal | - | - |
John Thomas
LAW | General Counsel | - | 01/09/21 |
Nate Rattner
AUD | Comptroller/Controller/Auditor | - | - |
John Karakkal
SAM | Sales & Marketing | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Daniel Janney
BRD | Director/Board Member | 58 | 01/11/16 |
Suma M. Krishnan
FOU | Founder | 59 | 15/04/16 |
Dino Rossi
BRD | Director/Board Member | 69 | 01/06/17 |
Chief Executive Officer | 59 | 15/04/16 | |
Julian Gangolli
BRD | Director/Board Member | 66 | 01/03/19 |
Director/Board Member | 57 | 01/09/17 | |
E. Sutherland
BRD | Director/Board Member | 54 | 18/01/22 |
Director/Board Member | 66 | 04/01/21 | |
Director/Board Member | 59 | 06/03/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 28 514 547 | 24 871 222 ( 87,22 %) | 0 | 87,22 % |
Coordinate società
Krystal Biotech, Inc.
2100 Wharton Street Suite 701
15203, Pittsburgh
+412 586 5830
http://www.krystalbio.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+26,45% | 4,47 Mrd | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,74 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione KRYS
- Società Krystal Biotech, Inc.